Patents by Inventor Daniel Klein
Daniel Klein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9817073Abstract: A battery management system for a high-voltage battery that has a switching device with controllable switching elements for establishing and disconnecting an electrical connection between the poles of the high-voltage battery and the connection points for a consumer network, and a device for insulation monitoring. The poles and connection points are each switched to a reference potential for insulation measurement via a voltage divider. The battery management system may have a device for checking the switching status of the controllable switching elements by means of measuring devices for determining the electrical voltage. The measuring devices are arranged so that they measure the voltage between the output of the respective voltage divider and the reference potential. The device for checking the switching status of the controllable switching elements has a device for comparing the measured voltage values of the two measuring devices.Type: GrantFiled: October 6, 2015Date of Patent: November 14, 2017Assignee: Hella KGaA Hueck & Co.Inventors: Daniel Klein, Georg Nau, Benjamin Schoening
-
Publication number: 20170247724Abstract: The invention pertains to a method for preparing cells that can be used as biocatalysts by inducing in them a growth-decoupled state, in which interferase inhibits the expression of genes except the ones that code for the pathway enzymes of interest. mRNAs that code for interferase-resistant products are overexpressed in the background of a metabolically-frozen cell. Enzymes that compete for a substrate or product of the pathway of interest may be altered such that the enzyme is sensitive to a site-specific protease, which protease is inducible in the host cell.Type: ApplicationFiled: March 17, 2017Publication date: August 31, 2017Applicant: GreenLight Biosciences, Inc.Inventor: Daniel Klein-Marcuschamer
-
Patent number: 9724550Abstract: A one part, solids containing decontamination blend composition comprises a solid acetyl donor coated with a compound that protects it from hydrolysis, a peroxygen source, optionally a catalyst, optionally a surfactant, and optionally a buffer. The decontamination blend composition is generally in a dry powder, particle, etc. form or in a tablet, pill, etc. form and is complete in and of itself in that no additional compounds are required prior to use and is readily distributed as a one package system. Upon the addition of water, a peroxygen compound such as hydrogen peroxide is formed, and peracetic acid is generated under alkaline conditions. The decontamination blend composition is particularly suitable for oxidizing various chemical and biological compounds thereby eradicating the same in situ as on surfaces, clothes, articles, and the like. Representative contaminants include mustard gas, nerve gas, bacterial toxins, anthrax, bird flu, and the like.Type: GrantFiled: August 15, 2006Date of Patent: August 8, 2017Assignees: American Sterilizer Company, The United States of America as represented by the Secretary of the ArmyInventors: Herbert J. Kaiser, Anchalee Thanavaro, Brandon W. Dell'Aringa, Bryan M. Tienes, Daniel A. Klein, George W. Wagner
-
Patent number: 9721695Abstract: The thermoplastic molding composition comprises, based on the thermoplastic molding composition, a) at least one polyamide, copolyamide or a polyamide-comprising polymer blend as component A, b) from 0.1 to 10% by weight of carbon nanotubes, graphenes or mixtures thereof as component B, c) from 0.1 to 3% by weight of ionic liquids as component C, wherein the thermoplastic molding composition does not comprise any polyamide-12 units.Type: GrantFiled: December 21, 2011Date of Patent: August 1, 2017Assignee: BASF SEInventors: Cecile Gibon, Xin Yang, Christof Kujat, Martin Weber, Laszlo Szarvas, Daniel Klein, Petra Poetschke, Beate Krause
-
Patent number: 9700644Abstract: A one part, solids containing decontamination blend composition comprises a solid acetyl donor coated with a compound that protects it from hydrolysis, a peroxygen source, optionally a catalyst, optionally a surfactant, and optionally a buffer. The decontamination blend composition is generally in a dry powder, particle, etc form or in a tablet, pill, etc form and is complete in and of itself in that no additional compounds are required prior to use and is readily distributed as a one package system. Upon the addition of water, a peroxygen compound such as hydrogen peroxide is formed, and peracetic acid is generated under alkaline conditions. The decontamination blend composition is particularly suitable for oxidizing various chemical and biological compounds thereby eradicating the same in situ as on surfaces, clothes, articles, and the like. Representative contaminants include mustard gas, nerve gas, bacterial toxins, anthrax, bird flu, and the like.Type: GrantFiled: July 24, 2007Date of Patent: July 11, 2017Assignees: American Sterilizer Company, The United States of America as Reresented by the Secretary of the ArmyInventors: Herbert J. Kaiser, Anchalee Thanavaro, Brandon W. Dell'Aringa, Bryan M. Tienes, Daniel A. Klein, George W. Wagner
-
Publication number: 20170147554Abstract: A method for configuring an automated dialogue system uses traces of interactions via a graphical user interface (GUI) for an application. Each trace includes interactions in the context of a plurality of presentations of the GUI. Elements of one or more presentations of the GUI are identified, and templates are associated with portions of the trace. Each template has one or more defined inputs and a defined output. For each template of the plurality of templates, the portions of the traces are processed to automatically configure the template by specifying a procedure for providing values of inputs to the template via the GUI and obtaining a value of an output. The automated dialogue system is configured with the configured templates, thereby avoiding manual configuration of the dialogue system.Type: ApplicationFiled: November 22, 2016Publication date: May 25, 2017Inventors: Pengyu Chen, Jordan R. Cohen, Laurence S. Gillick, David Leo Wright Hall, Daniel Klein, Adam D. Pauls, Daniel L. Roth, Jesse Daniel Eskes Rusak
-
Publication number: 20170140755Abstract: An interaction assistant conducts multiple turn interaction dialogs with a user in which context is maintained between turns, and the system manages the dialog to achieve an inferred goal for the user. The system includes a linguistic interface to a user and a parser for processing linguistic events from the user. A dialog manager of the system is configured to receive alternative outputs from the parser, and selecting an action and causing the action to be performed based on the received alternative outputs. The system further includes a dialog state for an interaction with the user, and the alternative outputs represent alternative transitions from a current dialog state to a next dialog state. The system further includes a storage for a plurality of templates, and wherein each dialog state is defined in terms of an interrelationship of one or more instances of the templates.Type: ApplicationFiled: November 10, 2016Publication date: May 18, 2017Inventors: Jacob Andreas, Taylor D. Being-Kirkpatrick, Pengyu Chen, Jordan R. Cohen, Laurence S Gillsick, David Leo Wright Hall, Daniel Klein, Michael Newman, Adam D. Pauls, Daniel L. Roth, Jesse Daniel Eskes Rusak, Andrew R. Volpe, Steven A. Wegmann
-
Patent number: 9637746Abstract: The invention pertains to a method for preparing cells that can be used as biocatalysts by inducing in them a growth-decoupled state, in which interferase inhibits the expression of genes except the ones that code for the pathway enzymes of interest. mRNAs that code for interferase-resistant products are overexpressed in the background of a metabolically-frozen cell. Enzymes that compete for a substrate or product of the pathway of interest may be altered such that the enzyme is sensitive to a site-specific protease, which protease is inducible in the host cell.Type: GrantFiled: December 14, 2009Date of Patent: May 2, 2017Assignee: GreenLight Biosciences, Inc.Inventor: Daniel Klein-Marcuschamer
-
Publication number: 20170096692Abstract: Provided herein are cell-free systems for generating carbapenems, e.g., a compound of the Formula (I): or salts thereof; wherein , R1, R2, R3, R4, R5 and R6 are defined herein. Also provided are pharmaceutical compositions comprising a compound generated by the inventive cell-free system, and use of these compounds and compositions for the treatment of bacterial infections.Type: ApplicationFiled: October 12, 2016Publication date: April 6, 2017Applicant: GreenLight Biosciences, Inc.Inventors: William Jeremy Blake, Daniel Klein-Marcuschamer
-
Patent number: 9469861Abstract: Provided herein are cell-free systems for generating carbapenems, e.g., a compound of the Formula (I): or salts thereof; wherein , R1, R2, R3, R4, R5, and R6 are defined herein. Also provided are pharmaceutical compositions comprising a compound generated by the inventive cell-free system, and use of these compounds and compositions for the treatment of bacterial infections.Type: GrantFiled: September 7, 2012Date of Patent: October 18, 2016Assignee: GreenLight Biosciences, Inc.Inventors: William Jeremy Blake, Daniel Klein-Marcuschamer
-
Publication number: 20160154064Abstract: A battery management system for a high-voltage battery that has a switching device with controllable switching elements for establishing and disconnecting an electrical connection between the poles of the high-voltage battery and the connection points for a consumer network, and a device for insulation monitoring. The poles and connection points are each switched to a reference potential for insulation measurement via a voltage divider. The battery management system may have a device for checking the switching status of the controllable switching elements by means of measuring devices for determining the electrical voltage. The measuring devices are arranged so that they measure the voltage between the output of the respective voltage divider and the reference potential. The device for checking the switching status of the controllable switching elements has a device for comparing the measured voltage values of the two measuring devices.Type: ApplicationFiled: October 6, 2015Publication date: June 2, 2016Inventors: Daniel Klein, Georg Nau, Benjamin Schoening
-
Publication number: 20150213457Abstract: A method for differentiating a commodity is provided. The method comprises establishing a predetermined set of protocols; establishing a standard for each protocol; collecting data from at least one user device; determining by one or more computing devices whether information regarding each of the protocols meets or exceeds an identified protocol compliance threshold; and identifying the commodity as a differentiated commodity when at least the plurality of the protocols meets or exceeds the identified protocol compliance threshold. The at least one user device is configured to send information regarding the protocols.Type: ApplicationFiled: January 27, 2014Publication date: July 30, 2015Applicant: Thales Energy, Inc.Inventors: Jason LIBERSKY, Daniel Klein, Joe Merlino, John Melby
-
Patent number: 9077318Abstract: The invention relates to a device for locking an adjusting means (5), in particular an electrical addressing device, mounted on a printed circuit board (1) which extends in an x and/or y direction. The device includes an essentially flat base plate (2) having a length (L), a width (B), and a thickness (D), to which a first detent spring (4) is attached for locking engagement with marking means (23, 23?) of the adjusting means (5). The first detent spring preferably has an oblong spring leg (7), wherein in the installed state the base plate (2) is mounted on the printed circuit board (1).Type: GrantFiled: April 26, 2013Date of Patent: July 7, 2015Assignee: Phoenix Contact GmbH & Co. KGInventors: Markus Becker, Rainer Gockel, Daniel Klein, Frank Hakemeyer, Christian Starke, Jürgen Kleinschmidt
-
Patent number: 8969282Abstract: A low odor, liquid disinfectant composition comprising multiple components, which, upon mixing, provide an aqueous solution comprising low levels of peracetic acid for use in decontaminating articles and surfaces contaminated with bacteria, viruses, fungi and other biological contaminants such as spores, including, but not limited to, Clostridium difficile (C.diff). The disinfectant composition is prepared just prior to use by combining two or more separately packaged components.Type: GrantFiled: February 5, 2009Date of Patent: March 3, 2015Assignee: American Sterilizer CompanyInventors: Christopher C. Heisig, Herbert J. Kaiser, Daniel A. Klein, Jessica S. Linder, Katie J. Frey, Nancy E. Kaiser, Jerry L. Newman
-
Patent number: 8958365Abstract: The invention relates to a radio network comprising a plurality of first clients which can communicate with one another by means of radio waves, wherein the first clients have at least one input unit for the input of data and/or at least one output unit for the output of data, wherein a first reference can be adjusted on one input unit and a second reference can be adjusted on one output unit, wherein the radio network is configured such that the incoming data to the input unit is communicated to the one or more output units the second reference thereof corresponding with the first reference adjusted on the input unit.Type: GrantFiled: September 17, 2010Date of Patent: February 17, 2015Assignee: Phoenix Contact GmbH & Co. KGInventors: Frank Hakemeyer, Daniel Klein, Andreas Senger
-
Patent number: 8715960Abstract: The present invention provides novel mitochondrial fusion transcripts, the parent mutated mtDNA molecules, and the resulting translation products (proteins) for predicting, diagnosing and/or monitoring cancer. Hybridization probes complementary thereto for use in the methods of the invention are also provided.Type: GrantFiled: March 29, 2010Date of Patent: May 6, 2014Assignee: Mitomics Inc.Inventors: Ryan Parr, Gabriel Dakubo, Andrew Harbottle, Brian Reguly, Jennifer Creed, Kerry Robinson, Daniel Klein
-
Patent number: 8518941Abstract: An extreme temperature decontamination composition such as a solution for destroying microorganisms, chemical warfare and bioterrorism agents is utilized that generally does not freeze at low temperatures down to about minus 25° F. and also has no significant evaporation or decomposition at temperatures up to about 120° F. The solution is effective against nerve agents and vesicants such as VX and HD, and various biological agents. The composition comprises a metallic salt of dichloroisocyanuric acid or dibromoisocyanuric acid, an aqueous solvent system comprising polar compounds such as water and an alkyl glycol, and a quasi hydrophilic compound. The composition can be formulated as a one part system wherein all components are blended together.Type: GrantFiled: August 19, 2010Date of Patent: August 27, 2013Assignee: American Sterilizer CompanyInventors: Herbert J. Kaiser, Daniel A. Klein, Anchalee Thanavaro, Miranda Chevon Shaver
-
Publication number: 20130065878Abstract: Provided herein are cell-free systems for generating carbapenems, e.g., a compound of the Formula (I): or salts thereof; wherein , R1, R2, R3, R4, R5, and R6 are defined herein. Also provided are pharmaceutical compositions comprising a compound generated by the inventive cell-free system, and use of these compounds and compositions for the treatment of bacterial infections.Type: ApplicationFiled: September 7, 2012Publication date: March 14, 2013Inventors: William Jeremy Blake, Daniel Klein-Marcuschamer
-
Patent number: D715502Type: GrantFiled: December 28, 2011Date of Patent: October 14, 2014Assignee: Neogen CorporationInventors: Daniel Klein, Ying Haiwen
-
Patent number: D796927Type: GrantFiled: May 11, 2016Date of Patent: September 12, 2017Assignee: Gustav Klauke GmBHInventors: Christoph Könnecke, Kai Daniel Klein, Torsten Darkow, Kevin Holohan